neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)

neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children aged 4 years and older who weigh at least 33 pounds (15 kg) ...
Morningstar

FDA Clears Amneal Epinephrine Injection

Amneal said that the Food and Drug Administration has approved its epinephrine injection in both single and multi-dose vials for hospitals. The Bridgewater, NJ-based biopharmaceutical company said ...
Investing

Amneal stock rises after FDA approves epinephrine injection

Investing.com -- Amneal Pharmaceuticals Inc Class A (NASDAQ:AMRX) stock rose 2.8% in after-hours trading Tuesday following the FDA approval of the company’s epinephrine injection USP, expanding its ...
Nasdaq

Amneal Wins FDA Nod For Epinephrine Injection In Single-and Multi-Dose Vials

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.
The Business Journals

Local medical device startup licenses epinephrine injector that fits in a smartphone

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
Investing

FDA approves Amneal’s epinephrine injection for emergency care

BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) announced Tuesday that the U.S. Food and Drug Administration has approved its epinephrine injection USP in both single-dose and ...
manilatimes

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal” or the "Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Seeking Alpha

Teva seeks removal of over 200 patents from FDA Orange Book after FTC challenge

The Federal Trade Commission announced on Wednesday that Teva Pharmaceutical (TEVA), under pressure from the agency, has requested the removal of more than 200 patents improperly listed in the FDA’s ...
MarketWatch

Game-Changing Allergy Rules: When to Use Epinephrine--and When You Can Skip the ER

The MarketWatch News Department was not involved in the creation of this content. 34-member international panel led by experts at Cincinnati Children's offers first consensus guidelines that seek to ...
FiercePharma

FTC claims a win as Teva moves to delist hundreds of patents from FDA Orange Book, agency says

For more than two years, the U.S. Federal Trade Commission (FTC) has been taking certain drugmakers to task over their alleged listing of "improper" patents in an FDA registry, a practice the agency ...
The Business Journals

Jefferson licenses doctor's smartphone innovation to Boston startup

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...